Medidata Unveils Transformative Solutions and Collaborations at NEXT New York, Driving Paradigm Shift in Life Sciences and Healthcare
New York – Nov. 13, 2024 – Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, is kicking off NEXT New York 2024, its premier life sciences conference. Uniting more than 1,000 healthcare customers and partners, the event will showcase AI-powered innovations that accelerate clinical trials, streamline data management, and enhance decision-making for life-saving therapies.
At the event, Medidata will unveil three experiences centered on the full ecosystem of clinical trials—data management, patient engagement, and study coordination—providing tools that streamline trial workflows and enhance patient lives. Powered by the world’s largest collection of anonymized and de-identified historical clinical trial data, AI continues to be a foundational element in everything Medidata offers, allowing these experiences to be infused with machine learning and other technologies, such as Medidata Designer and Medidata Rave Lite.
“NEXT New York is our most important event of the year, and we're excited to share new insights and fresh approaches,” said Anthony Costello, CEO, Medidata. “Across two days, we’ll immerse our customers in clinical development, offering insights into our shift from individual products to integrated, patient-centered experiences. We’ll also highlight strategies that simplify trial operations, enhance patient engagement, and prioritize effective data capture and integration from ever more complex sources.”
The conference will feature over 35 customer and partner speeches, from Cogstate, Click Therapeutics, CNS Healthcare, Snowflake, and more, exploring such diverse topics such as AI’s profound impact on clinical research, the extension of longitudinal relationships with patients, and more.
Conference participants will also engage in 28 breakout sessions covering topics that include AI-enabled trial design, central nervous system trials, and more. Additionally, they can join in on three immersive experiences, including the lifecycle of a site from the sponsor's perspective, a data point journey from acquisition to application, and a day-in-the-life of a clinical trial patient. These hands-on demos will provide exclusive insights into Medidata's cutting-edge solutions and site relationships.
To learn more about Medidata NEXT New York, click here, and to register for virtual keynote sessions, click here.
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. With Dassault Systèmes’ 3DEXPERIENCE platform, 350,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact. For more information, visit: https://www.3ds.com